View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Fortum : Une bonne publication mais peu de perspectives

>Un résultat supérieur aux attentes - L'EBITDA comparable s'est élevé à 622 M€ (-20 %YoY), au-dessus de nos attentes de 525 M€ et du consensus Vara de 549 M€. L’EBIT comparable s'élève à 530 M€ (-24%) au-dessus de notre prévision et du consensus à 452 M€. Le résultat net a également été meilleur qu'attendu à 430 M€ (-11%) contre 350 M€ attendus (ODDO BHF et consensus). Par division la surprise vient de l’activité génération électrique avec un EBIT de 513 M€ (-29%) con...

Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Fortum : A good publication but limited prospects

>Earnings top estimates - Comparable EBITDA totalled € 622m in Q1 2024 (-20% y-o-y), above our expectations of € 525m and the Vara consensus estimate of € 549m. Comparable EBIT was € 530m (-24%), above our forecast and the consensus of € 452m. Net profit was also better than expected, at € 430m (-11%) against an expected € 350m (ODDO BHF and the consensus). By division, the surprise came from the electricity generation business, which performed better than expected, ...

 PRESS RELEASE

Press Release: Beyfortus real-world evidence published in The Lancet s...

Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention1-6Results add to the consistent high efficacy of Beyfortus against medically attended RSV lower respiratory tract disease, shown in the pivotal clinical studies and the o...

 PRESS RELEASE

Communiqué de presse : Des données de vie réelle concernant Beyfortus ...

Communiqué de presse : Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS De nouvelles données de vie réelle montrent que Beyfortus (nirsevimab) a permis de réduire sensiblement les infections des voies respiratoires inférieures dues au VRS chez les nourrissons, de même que les hospitalisations, au cours de la saison virale 2023-2024, compa...

 PRESS RELEASE

City of Oceanside and ENGIE Announce a 30-year Comprehensive Energy P...

City of Oceanside and ENGIE Announce a 30-year Comprehensive Energy Project Oceanside, California and Houston, May 01, 2024 (GLOBE NEWSWIRE) -- The City of Oceanside, in collaboration with ENGIE North America (ENGIE), announced plans for a transformative energy initiative aimed at enhancing sustainability, reducing costs and fostering community engagement. This comprehensive 30-year initiative is projected to generate more than $26,000,000 in net savings for the City. It includes significant energy efficiency gains through a series of strategic measures, including: integrating 1.6 mega...

Pierre FerraguÊ
  • Pierre FerraguÊ

What if the EV slowdown were not a headwind on auto semi growth?

EV adoption is slowing in the West, but to the benefit of hybrids. Is this well understood by those investing in auto semi stocks?

Sanofi: 1 director

A director at Sanofi bought 1,000 shares at 91.380EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

 PRESS RELEASE

Press Release: Annual General Meeting of April 30, 2024

Press Release: Annual General Meeting of April 30, 2024 Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board composition: renewal of two Directors and appointment of three new Independent Directors Paris, April 30, 2024. The Combined General Shareholders’ Meeting of Sanofi was held on April 30, 2024, under the chairmanship of Frédéric Oudéa. All resolutions submitted to the vote were adopted by the shareholders. The General Meeting approved the indi...

 PRESS RELEASE

Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2024

Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2024 Assemblée Générale Annuelle du 30 avril 2024 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2023Distribution d’un dividende en numéraire de 3,76 euros par action, dont la mise en paiement interviendra le 15 mai 2024Composition du Conseil d’administration : renouvellement de deux administrateurs et nomination de trois nouveaux administrateurs indépendants Paris, le 30 avril 2024. L’Assemblée Générale Mixte des actionnaires de Sanofi s’est réunie le 30 avril 2024, sous la présidence de Frédéric ...

 PRESS RELEASE

Vivendi : Descriptif du programme de rachat d’actions autorisé par l’A...

PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV): Le présent descriptif est établi en application des dispositions des articles 241-1 et 241-2 du Règlement général de l’Autorité des marchés financiers. 1. Date de l’Assemblée générale ayant autorisé le programme de rachat d’actions et de mise en œuvre. L’autorisation d’achat par la société de ses propres actions a été donnée par l’Assemblée générale mixte du 29 avril 2024 (vingt-et-unième résolution). Elle est mise en œuvre sur délégation du Directoire du 29 avril 2024. 2. Nombre de titres et part du capital détenu direct...

Jean Danjou ... (+2)
  • Jean Danjou
  • Oliver Metzger

ODDO BHF Small & MIDCAP MORNING NEWS - 04/30/2024

BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - ...

Jean Danjou ... (+2)
  • Jean Danjou
  • Oliver Metzger

ODDO BHF Small & MIDCAP MORNING NEWS - 30/04/2024 Date Performance dep...

L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) vs Au...

Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 04/30/2024

BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - ...

Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 30/04/2024

L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) vs Au...

Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Fortum : Good result but significant degradation in hedged position

>Good performance in the Q1 2024… - For the Q1 2024 Comparable EBITDA was € 622m (-20% y-o-y), above our assumptions at € 525m and Vara consensus estimate of € 549m. Comparable operating profit totalled € 530m (-24%) above our forecast and consensus at € 452m. Net income was also better than expected at € 430m (-11%) vs € 350m expected (ODDO BHF and consensus). In spite of lower prices, the drop in earnings was more limited than anticipated in the generation business ...

Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Fortum : Good result but significant degradation in hedged position

>Good performance in the Q1 2024… - For the Q1 2024 Comparable EBITDA was € 622m (-20% y-o-y), above our assumptions at € 525m and Vara consensus estimate of € 549m. Comparable operating profit totalled € 530m (-24%) above our forecast and consensus at € 452m. Net income was also better than expected at € 430m (-11%) vs € 350m expected (ODDO BHF and consensus). In spite of lower prices, the drop in earnings was more limited than anticipated in the generation business ...

Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

Nokian Renkaat Oyj : Début d’année plus difficile que prévu

>Résultats inférieurs aux attentes mais guidance confirmée - Nokian Tyres a publié des résultats T1 2024 nettement inférieurs à nos attentes et celles du consensus avec un CA seulement stable à 237 M€ (consensus 265 M€) et un EBIT ajusté de -15 M€ (consensus +4 M€, ODDO BHF -3 M€), notamment pénalisé par des facteurs externes (grèves en Finlande, impacts Mer Rouge) qui ont davantage impacté sa production que ce que nous anticipions (impact CA de ~25 M€ au T1) et qui ...

 PRESS RELEASE

Michelin : Disclosure of trading in own shares - April 30th 2024

Michelin : Disclosure of trading in own shares - April 30th 2024 23, Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR 0000121261Date : April 30th, 2024 Issuer NameIssuer codeTransactiondateISIN CodeDaily total volume (in number of actions)Daily weighted average price of shares acquiredPlatformCompagnie Générale des Etablissements Michelin549300SOSI58J6VIW05202.05.2024FR001400AJ45174 87334,4024 eurosGré à g...

 PRESS RELEASE

Michelin : Déclaration des transactions sur actions propres - 30/04/20...

Michelin : Déclaration des transactions sur actions propres - 30/04/2024 23, Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Informations sur les opérations réalisées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéInformation réglementée Dénomination sociale de l’émetteur : Michelin – LEI 549300SOSI58J6VIW052Référence de l’instrument financier : Actions ordinaires – Code ISIN FR 0000121261Date : 30 avril 2024 Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l'instrument financierVolume total journalier (en nombre d'actio...

Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

Nokian Renkaat Oyj : A tougher start to the year than expected

>Earnings short of estimates but guidance confirmed - Nokian Tyres reported Q1 2024 earnings far below our estimates and those of the consensus with sales merely stable at € 237m (consensus € 265m and adjusted EBIT of -€ 15m (consensus +€ 4m, ODDO BHF -€ 3m), notably penalised by external factors (strikes in Finland, disruptions in the Red Sea) which have hit the group’s production harder than we expected (sales impact of ~€ 25m in Q1), and which should continue to af...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch